TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/24 14:08 | 4/19/24 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | FL | OT | Chief Sc | P.ad | 120 | 8.32 | 0 | 14 | 1 | 1,511 | D | ||||||||||||||
11/4/21 16:00 | 11/3/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | FL | OT | Chief Sc | S | -14 | 20.00 | 0 | -1 | 0 | 1,473 | D | ||||||||||||||
10/29/21 16:03 | 10/27/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | FL | OT | Chief Sc | S | -47 | 20.00 | 0 | -2 | 0 | 1,473 | D | ||||||||||||||
10/26/21 16:31 | 10/22/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | FL | OT | Chief Sc | S | -8 | 20.00 | 0 | 0 | 0 | 1,476 | D | ||||||||||||||
7/9/21 16:06 | 7/7/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | FL | O | Chief Sc | S.m | -605 | 20.16 | 0 | -30 | -2 | 1,476 | D | ||||||||||||||
9/12/19 21:15 | 9/11/19 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | CA | OT | Chief Sc | P | 18 | 6.23 | 0 | 3 | 0 | 1,506 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |